Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 4
1965 3
1969 4
1970 5
1971 10
1972 7
1973 11
1974 18
1975 27
1976 21
1977 18
1978 16
1979 4
1980 5
1981 17
1982 17
1983 18
1984 30
1985 26
1986 33
1987 23
1988 26
1989 25
1990 30
1991 34
1992 31
1993 35
1994 29
1995 46
1996 51
1997 47
1998 53
1999 47
2000 53
2001 51
2002 54
2003 47
2004 46
2005 49
2006 53
2007 73
2008 55
2009 45
2010 43
2011 62
2012 64
2013 64
2014 69
2015 47
2016 58
2017 65
2018 66
2019 60
2020 58
2021 54
2022 44
2023 52
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,995 results

Results by year

Filters applied: . Clear all
Page 1
Primary systemic amyloidosis.
Gertz MA, Rajkumar SV. Gertz MA, et al. Curr Treat Options Oncol. 2002 Jun;3(3):261-71. doi: 10.1007/s11864-002-0016-1. Curr Treat Options Oncol. 2002. PMID: 12057072 Review.
The least invasive source of tissue for amyloid detection is the subcutaneous fat. The most important prognostic factor is whether there is cardiac involvement, which is best assessed by echocardiography with Doppler studies. ...
The least invasive source of tissue for amyloid detection is the subcutaneous fat. The most important prognostic factor is whether th …
Primary systemic amyloidosis.
Comenzo RL. Comenzo RL. Curr Treat Options Oncol. 2000 Apr;1(1):83-9. doi: 10.1007/s11864-000-0018-9. Curr Treat Options Oncol. 2000. PMID: 12057064 Review.
Otherwise, AL patients who are elderly or ineligible for autologous transplantation may be treated with oral melphalan (Alkeran, GlaxoWellcome, Middlesex, UK) and prednisone; however, because the response rate is only about 25% and the prognosis poor, such patients might a …
Otherwise, AL patients who are elderly or ineligible for autologous transplantation may be treated with oral melphalan (Alkeran, GlaxoWellco …
Neonatal jaundice.
McKiernan P. McKiernan P. Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):253-6. doi: 10.1016/j.clinre.2012.03.018. Epub 2012 May 18. Clin Res Hepatol Gastroenterol. 2012. PMID: 22609294
Babies with the neonatal hepatitis syndrome should have vigorous fat-soluble vitamin supplementation, including parenteral vitamin K if coagulation is abnormal. The prognosis for infants with idiopathic neonatal hepatitis and multifactorial cholestasis is excellent....
Babies with the neonatal hepatitis syndrome should have vigorous fat-soluble vitamin supplementation, including parenteral vitamin K if coag …
An ACE diagnosis.
Nasher O, Gupta A. Nasher O, et al. BMJ Case Rep. 2013 Feb 14;2013:bcr2012008185. doi: 10.1136/bcr-2012-008185. BMJ Case Rep. 2013. PMID: 23417380 Free PMC article.
Long-term follow-up of a patient with neonatal form of Gaucher disease.
Gragnaniello V, Cazzorla C, Gueraldi D, Loro C, Massa P, Puma A, Cananzi M, Salviati L, Burlina AP, Burlina AB. Gragnaniello V, et al. Am J Med Genet A. 2023 Jul;191(7):1917-1922. doi: 10.1002/ajmg.a.63196. Epub 2023 Apr 3. Am J Med Genet A. 2023. PMID: 37009750
Castleman's disease.
Slotwiner A, Garwacki CP, Moll S. Slotwiner A, et al. Am J Hematol. 2003 May;73(1):64-5. doi: 10.1002/ajh.10318. Am J Hematol. 2003. PMID: 12701124 Free article. No abstract available.
Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation.
Tahata S, Weckwerth J, Ligezka A, He M, Lee HE, Heimbach J, Ibrahim SH, Kozicz T, Furuya K, Morava E. Tahata S, et al. Mol Genet Metab. 2023 Apr;138(4):107559. doi: 10.1016/j.ymgme.2023.107559. Epub 2023 Mar 17. Mol Genet Metab. 2023. PMID: 36965289 Free PMC article.
1,995 results